Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Revenue	$ 43,098	$ 37,704	$ 130,508	$ 105,958
Costs of sales	32,100	27,751	95,332	75,512
Gross profit	10,998	9,953	35,176	30,446
Operating expenses:
Selling, general and administrative	20,069	11,156	56,876	31,537
Investigation and restatement expenses	0	1,408	4,303	13,122
Integration and acquisition costs	0	24	0	1,127
Depreciation and amortization	1,107	1,083	3,209	3,359
Total operating expenses	21,176	13,671	64,388	49,145
Operating loss	(10,178)	(3,718)	(29,212)	(18,699)
Other income (expense):
Interest income	411	348	988	1,245
Interest expense	(683)	(913)	(1,981)	(2,518)
Change in fair value of derivative	1,070	0	1,070	0
Total other income (expense), net	798	(565)	77	(1,273)
Loss before income taxes	(9,380)	(4,283)	(29,135)	(19,972)
Benefit (provision) for income taxes	85	(23)	(46)	(60)
Net loss	(9,295)	(4,306)	(29,181)	(20,032)
Preferred dividends	(334)	(334)	(668)	(668)
Net loss applicable to common shares	$ (9,629)	$ (4,640)	$ (29,849)	$ (20,700)
Net loss per common share
Basic (in dollars per share)	$ (0.15)	$ (0.08)	$ (0.48)	$ (0.34)
Diluted (in dollars per share)	$ (0.15)	$ (0.08)	$ (0.48)	$ (0.34)
Weighted average number of common shares outstanding
Basic (in shares)	64,096,778	60,065,053	62,591,947	60,059,594
Diluted (in shares)	64,096,778	60,065,053	62,591,947	60,059,594
Service
Revenue	$ 34,961	$ 31,515	$ 105,324	$ 89,919
Costs of sales	22,244	20,307	66,912	58,141
Product
Revenue	8,137	6,189	25,184	16,039
Costs of sales	$ 9,856	$ 7,444	$ 28,420	$ 17,371